Andrew Mammen Selected Research

Andrew Mammen Research Topics

8	Muscular Diseases (Myopathy) 01/2022 - 09/2010
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 01/2014
3	Myalgia 01/2018 - 01/2016
2	Muscle Weakness 01/2016 - 09/2010
1	Autoimmune Diseases (Autoimmune Disease) 02/2022
1	malar rash 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Cataract (Cataracts) 01/2022
1	Confusion (Bewilderment) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Pulmonary Hypertension 01/2022
1	Pericarditis 01/2022
1	Pleurisy (Pleuritis) 01/2022
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2022
1	Cognitive Dysfunction 01/2022
1	Inflammation (Inflammations) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2018
1	Stroke (Strokes) 10/2016
1	Necrosis 10/2016
1	Myocardial Infarction 10/2016
1	Polymyositis 01/2016
1	Dermatomyositis (Dermatopolymyositis) 01/2016
1	Disease Progression 01/2016
1	Muscular Atrophy (Muscle Atrophy) 09/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2015
1	Alzheimer Disease (Alzheimer's Disease) 05/2011

5	AntibodiesIBA 01/2022 - 09/2010
5	AutoantibodiesIBA 01/2020 - 01/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2014
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 09/2010
3	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 01/2016
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2022 - 01/2016
1	Ligases (Synthetase)IBA 02/2022
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	Coenzyme A (CoA)IBA 10/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	cerivastatin (Kazak)FDA Link 01/2016
1	EnzymesIBA 01/2016
1	env Gene ProductsIBA 09/2015
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2014
1	Peptides (Polypeptides)IBA 05/2011
1	Amyloid (Amyloid Fibrils)IBA 05/2011
1	Proteins (Proteins, Gene)FDA Link 05/2011
1	Signal Recognition ParticleIBA 09/2010
1	Rituximab (Mabthera)FDA Link 09/2010
1	Monoclonal AntibodiesIBA 09/2010